Qingqiang Dai

Shanghai First Maternity and Infant Hospital

Papers

1

Total Citations

20

H-Index

1

About

Dr. Qingqiang Dai is a leading figure in gynecologic surgery, with a focused expertise in minimally invasive treatments for pelvic organ prolapse (POP). Their most cited work, a 2023 prospective cohort study, directly compares the effectiveness of laparoscopic pectopexy against the gold-standard laparoscopic sacrocolpopexy. This research, which has garnered 20 citations, provides critical clinical evidence on surgical outcomes for POP patients. Dr. Dai’s major contribution lies in rigorously evaluating and advancing alternative surgical techniques that aim to reduce operative complexity and improve patient recovery without compromising anatomical success. By conducting this study at a tertiary hospital with over 200 patients, they have generated high-quality, comparative data that informs surgical decision-making. Their work is particularly notable for addressing a key clinical question in urogynecology, helping to refine best practices for a common and debilitating condition. Dr. Dai’s research is essential reading for surgeons and trainees seeking evidence-based approaches to pelvic floor reconstruction.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Effectiveness of Laparoscopic Pectopexy for Pelvic Organ Prolapse Compared with Laparoscopic Sacrocolpopexy
20 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Shanghai First Maternity and Infant Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago